Advertisement

Topics

SCYNEXIS, Inc. Company Profile

05:13 EDT 20th September 2017 | BioPortfolio

SCYNEXIS, Inc. is a chemistry-focused drug discovery and development company headquartered in Research Triangle Park, North Carolina. Its scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery of innovative medicines over a broad range of therapy areas.In the discovery phase SCYNEXIS offers its services primarily in the form of integrated research teams consisting of medicinal chemists, computational chemists, analytical chemists and bioanalytical scientists to work on a collaborative basis with our customers on projects from hit to candidate selection. SCYNEXIS project leaders of these multi-disciplinary teams are knowledgeable scientists with years of industry experience. They coordinate and communicate key activities and drive resources to achieve success. SCYNEXIS research teams use powerful, proprietary technologies such as the HEOS® Software Suite, MEDCHEM-FACTORY™ and KIT™ Kinase Inhibitor Technology to deliver maximum results to our customers.

Location

Post Office Box 12878
Research Triangle Park
North Carolina
27709-2878
United States of America

Contact

Phone: (919) 544-8600
Fax: (919) 544-8697
Email: Market.Development@scynexis.com


News Articles [24 Associated News Articles listed on BioPortfolio]

Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in SCYNEXIS, Inc. of Class Action Lawsuit and Upcoming Deadline - SCYX

NEW YORK, NY / ACCESSWIRE / May 5, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against SCYNEXIS, Inc. ("Scynexis" or the "Company") (NASDAQ: SCYX) and certain of its o...

DEADLINE TODAY: Lundin Law PC Announces a Securities Class Action Lawsuit against SCYNEXIS, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 8, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX) concernin...

Scynexis stock slumps as clinical hold continues

The FDA's request for more analysis of preclinical and clinical data looks like it will push further clinical development of Scynexis' IV antifungal even further back. 

DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of SCYNEXIS, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 8, 2017 - SCYX

NEW YORK, NY / ACCESSWIRE / May 8, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of SCYNEXIS, I...

Scynexis Q2 - Steady As She Goes

Scynexis: A $2 'Busted IPO' And Lottery Ticket?

Scynexis: Another Buy Opportunity On The Recent Pullback

Scynexis: Time To Abandon Ship?

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

SCYNEXIS, Inc.

SCYNEXIS, Inc. is a chemistry-focused drug discovery and development company headquartered in Research Triangle Park, North Carolina. Its scientists have extensive experience in the life sciences indu...

More Information about "SCYNEXIS, Inc." on BioPortfolio

We have published hundreds of SCYNEXIS, Inc. news stories on BioPortfolio along with dozens of SCYNEXIS, Inc. Clinical Trials and PubMed Articles about SCYNEXIS, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SCYNEXIS, Inc. Companies in our database. You can also find out about relevant SCYNEXIS, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record